|
| 37344685 | Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France. | Eur J Health Econ | 2024 |
| 37814421 | Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. | Pediatr Blood Cancer | 2024 |
| 37418281 | A 10-year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases? | Andrology | 2024 |
| 37344685 | Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France. | Eur J Health Econ | 2024 |
| 37814421 | Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. | Pediatr Blood Cancer | 2024 |
| 37418281 | A 10-year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases? | Andrology | 2024 |
| 36264505 | Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours. | Acta Neuropathol | 2023 |
| 36264505 | Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours. | Acta Neuropathol | 2023 |
| 37900191 | Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous Humor. | Ocul Oncol Pathol | 2023 |
| 37091147 | Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks. | Front Oncol | 2023 |
| 36645217 | Changing incentives to ACCELERATE drug development for paediatric cancer. | Cancer Med | 2023 |
| 37015036 | Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents. | J Clin Oncol | 2023 |
| 36810692 | Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor Treatment. | J Clin Endocrinol Metab | 2023 |
| 37318080 | Risk factors for obesity in adulthood among survivors of childhood cancer. | Obesity (Silver Spring) | 2023 |
| 36808285 | Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. | Neuro Oncol | 2023 |
| 37444642 | Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors. | Cancers (Basel) | 2023 |
| 37119099 | How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors? | J Neurosurg Pediatr | 2023 |
| 37434345 | Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis. | Expert Rev Anticancer Ther | 2023 |
| 36470558 | Retinoblastoma: From genes to patient care. | Eur J Med Genet | 2023 |
| 37171700 | Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol. | J Neurooncol | 2023 |
| 36794424 | GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy? | J Clin Endocrinol Metab | 2023 |
| 36726302 | Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015. | Cancer Med | 2023 |
| 37541786 | Germline <i>HPF1</i> retrogene insertion in <i>RB1</i> gene involved in cancer predisposition. | J Med Genet | 2023 |
| 36657724 | The risk of valvular heart disease in the French Childhood Cancer Survivors' Study: Contribution of dose-volume histogram parameters. | Radiother Oncol | 2023 |
| 37900191 | Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous Humor. | Ocul Oncol Pathol | 2023 |
| 37541786 | Germline <i>HPF1</i> retrogene insertion in <i>RB1</i> gene involved in cancer predisposition. | J Med Genet | 2023 |
| 37318080 | Risk factors for obesity in adulthood among survivors of childhood cancer. | Obesity (Silver Spring) | 2023 |
| 37119099 | How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors? | J Neurosurg Pediatr | 2023 |
| 37015036 | Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents. | J Clin Oncol | 2023 |
| 37444642 | Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors. | Cancers (Basel) | 2023 |
| 37171700 | Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol. | J Neurooncol | 2023 |
| 37434345 | Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis. | Expert Rev Anticancer Ther | 2023 |
| 37091147 | Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks. | Front Oncol | 2023 |
| 36810692 | Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor Treatment. | J Clin Endocrinol Metab | 2023 |
| 36470558 | Retinoblastoma: From genes to patient care. | Eur J Med Genet | 2023 |
| 36808285 | Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. | Neuro Oncol | 2023 |
| 36645217 | Changing incentives to ACCELERATE drug development for paediatric cancer. | Cancer Med | 2023 |
| 36794424 | GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy? | J Clin Endocrinol Metab | 2023 |
| 36726302 | Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015. | Cancer Med | 2023 |
| 36657724 | The risk of valvular heart disease in the French Childhood Cancer Survivors' Study: Contribution of dose-volume histogram parameters. | Radiother Oncol | 2023 |
| 34460114 | A malignant choroid plexus tumour with prevailing immature blastematous elements. | Neuropathol Appl Neurobiol | 2022 |
| 36302943 | Long-term hospitalisations in survivors of paediatric solid tumours in France. | Sci Rep | 2022 |
| 35617253 | Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM). | PLoS One | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 35985866 | [Announcing treatment resistance in pediatric oncology: A qualitative study of nurses' experiences]. | Bull Cancer | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 34918112 | High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort. | J Clin Endocrinol Metab | 2022 |
| 34460114 | A malignant choroid plexus tumour with prevailing immature blastematous elements. | Neuropathol Appl Neurobiol | 2022 |
| 35254670 | Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients. | J Pathol | 2022 |
| 34850167 | Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors. | Neuro Oncol | 2022 |